BLMH Blocking Peptide (Center)
€363.00
In stock
SKU
AC-BP20463c
Background:
The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity (By similarity).
Other Names:
Bleomycin hydrolase, BH, BLM hydrolase, BMH, BLMH
Target/Specificity:
The synthetic peptide sequence is selected from aa 229-242 of Human BLMH
Gene Name: BLMH
Gene ID: 642
Primary Accession: Q13867
Other Accession: P70645; P13019; Q8R016
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity (By similarity).
Other Names:
Bleomycin hydrolase, BH, BLM hydrolase, BMH, BLMH
Target/Specificity:
The synthetic peptide sequence is selected from aa 229-242 of Human BLMH
Gene Name: BLMH
Gene ID: 642
Primary Accession: Q13867
Other Accession: P70645; P13019; Q8R016
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review